Whistleblower details GSK plant failures on TV; Five dead in China plant explosion;

> Whistleblower Cheryl Eckard tells 60 Minutes what she saw in 2002 at GlaxoSmithKline's Cidra, Puerto Rico, plant that led the drug giant to a guilty plea and $750 million settlement for distributing adulterated drugs. GSK says it regrets the Cidra manufacturing issues. Article | 13-minute Video | GSK response

> Five workers are reported dead and eight others injured, some with serious burns, in an explosion at the Quanxin Pharmaceutical plant in southwest China. Article

> A financial analyst expects the trend of increasing prices on key biotech drugs that began last year to continue in 2011, despite healthcare reform. Story

> The FDA has become a member of the Pharmaceutical Inspection Convention and the Pharmaceutical Inspection Cooperation Scheme (PIC/S). Item

> The European Medicines Agency anticipates similar workloads for drug applications and practically no increases to its budget for that work program in 2011. Report

> Particle contamination has driven another product recall: six lots of injectable acetylcysteine (Acetadote) manufactured by Cumberland Pharmaceuticals. Cumberland release

> Hong Kong is launching a name-and-shame campaign against retailers caught selling counterfeit medicines. Article

> Elder Pharmaceuticals says it has received approval from the Japan health ministry for its manufacturing facility in the West Indian state of Maharashtra. Report

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.